Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.05.2024 | Case report

Immunosuppressants/semaglutide/ursodeoxycholic-acid

Drug-induced liver injury and lack of efficacy

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Ma J, et al. Progressive Cholestasis and Biliary Cirrhosis after Initiating Oral Semaglutide: Report from the Drug-Induced Liver Injury Network. ACG Case Reports Journal 9: No. 12, Dec 2022. Available from: URL: 10.14309/crj.0000000000000922 Ma J, et al. Progressive Cholestasis and Biliary Cirrhosis after Initiating Oral Semaglutide: Report from the Drug-Induced Liver Injury Network. ACG Case Reports Journal 9: No. 12, Dec 2022. Available from: URL: 10.14309/crj.0000000000000922
Metadaten
Titel
Immunosuppressants/semaglutide/ursodeoxycholic-acid
Drug-induced liver injury and lack of efficacy
Publikationsdatum
01.05.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-58221-9

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Phenytoin